Unlearn.AI
Healthcare Software · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
303 2nd St Ste N460, San Francisco, Cali...Website
www.unlearn.aiRevenue
$12.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
5
2
4
2
2
About Unlearn.AI
Unlearn.AI is a San Francisco startup founded in 2017 by former Pfizer principal scientist Charles Fisher. The firm claims to be the first to create 'digital twins' to populate intelligent control arms in clinical studies. In the context of clinical research, Unlearn explains, a digital twin is a "longitudinal, computationally generated clinical record that describes what would have happened if a specific patient received a placebo". Digital twins integrate data from real patients with the aim of replacing them in placebo control groups. By removing the need for placebo-controlled cohorts, they could reduce the number of participants needed for clinical trials. According to the firm, digital twins can also increase study power by decreasing variability, as well as powering secondary endpoints and exploratory analyses and providing additional evidence to understand how each patient responded to an experimental treatment in a trial. Currently, the company is focusing its DiGenesis machinRead more
Unlearn.AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Unlearn.AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Unlearn.AI, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Unlearn.AI
Check if Unlearn.AI has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Unlearn.AI launches new products
Funding: Get notified immidiatlly once Unlearn.AI has new funding data
Earning: See what the market has to say on Unlearn.AI recently announced quarterly report
Check out if Unlearn.AI is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Unlearn.AI had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Unlearn.AI
Find 2 more new buyers
Compare Similar Companies to Unlearn.AI
Compare insights from companies similar to Unlearn.AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Unlearn.AI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Unlearn.AI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Unlearn.AI.
Unlearn.AI financials insights
Gather financial insights about Unlearn.AI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$15M
2023
Other Financing Round
$15M
2024
Multiple Rounds
$150M
Unlearn.AI Tech Stack
A closer look at the technologies used by Unlearn.AI
Most Recent Scoops
Open Position
Open Position
Open Position
Hiring Plans
Unlearn.AI has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Python, Figma, Amazon AWS, and C.
Hiring Plans
Open Position
Unlearn.AI News & Media
Unlearn Appoints Krates Ng as Chief Technology Officer
SAN FRANCISCO--(BUSINESS WIRE)--Unlearn® announced Krates Ng as its Chief Technology Officer. Ng will build technical and operational foundations for their AI technologies.Digital twin company Unlearn partners with Trace Neuroscience | MobiHealthNews
Trace will use Unlearn's digital twin generator for ALS to create digital twins of clinical trial participants to advance ALS research.Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Unlearn® and Trace Neuroscience are partnering to use Unlearn’s Digital Twin Generator for Trace Neuroscience Phase 1/2 ALS clinical trial.Unlearn’s 2024 Achievements Drive Innovation in AI for Clinical Development
SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn achieved key milestones in advancing AI to eliminate trial and error in medicine.
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Unlearn.AI
Sign Up For FreeTo access detailed company insights
Unlearn.AI is a San Francisco startup founded in 2017 by former Pfizer principal scientist Charles Fisher. The firm claims to be the first to create 'digital twins' to populate intelligent control arms in clinical studies. In the context of clinical research, Unlearn explains, a digital twin is a "longitudinal, computationally generated clinical re... Read More
